期刊文献+

MicroRNA-429对人肺癌A549细胞生长的影响

Effect of MicroRNA-429 on Cell Growth in Human Lung Cancer Cell Line A549
原文传递
导出
摘要 目的:探讨microRNA-429(miR-429)对人肺癌A549细胞增殖和凋亡的影响。方法:定量逆转录聚合酶链反应(qPCR)技术检测A549细胞瞬时转染miR-429mimic或inhibitor后miR-429的表达;通过MTT法和流式细胞术检测转染后细胞增殖能力和凋亡变化。结果:瞬时转染miR-429mimic 24h后,qPCR结果显示miR-429表达显著升高(9.3±0.3比1.0±0.1,P<0.05),而转染miR-429inhibitor可以显著降低miR-429表达(0.3±0.0比1.0±0.1,P<0.05);与对照组相比,过表达miR-429抑制肿瘤细胞增殖(2.8±0.2比5.0±0.3,P<0.05)并诱导凋亡(18.9±1.2比12.3±1.0,P<0.05),而下调miR-429表达促进肿瘤细胞增殖(6.3±0.4比5.0±0.3,P<0.05)并抑制凋亡(7.1±0.6比12.3±1.0,P<0.05)。结论:miR-429在肺癌中可能作为肿瘤抑制因子发挥功能。 Objective: To investigate the effect oI microRNA-429 (mlN-4Zg) on the proliferation and ap optosis of lung cancer cells. Methods: We detected expression of miR-429 after miR-429 mimic and its inhibitor were transiently transfected into human lung cancer cell line A549. The cell proliferation and apoptosis after transfection were analyzed by MTT and flow cytometry. Results: 24 h after miR-429 mimic transfection, the expression of miR-429 was significantly up-regulated (9.3±0.30 vs 1.0±0.08, P〈0.05). However, miR-429 inhibitor transfection led to downregulation of miR-429(0.3±0.05 vs 1.0±0.08, P〈0.05). Compared with control transfection, miR-429 overexpression inhibited tumor cell proliferation (2.8±0.21 vs 5.04±0.27, P〈0.05) and induced cell apoptosis significantly (18.9±1.2 vs 12.3±1.0, P〈0.05). On the contrary, downregulation of miR-429 promoted tumor cell proliferation (6.3 ± 0.35 vs 5.0 ±0.27, P〈 0.05) and inhibited cell apoptosis significantly (7.1±0.6 vs 12.3±1.0, P〈0.05). Conclusion: MiR-429 may serve as a tumor suppressor and may be a potential therapeutic target in lung cancer.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2014年第2期198-201,共4页 Medical Journal of Wuhan University
关键词 microRNA-429 肺癌 增殖 凋亡 microRNA-429 Lung Cancer Proliferation Apoptosis
  • 相关文献

参考文献3

二级参考文献30

  • 1杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 2Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12:861-74.
  • 3Bhatt K, Mi QS, Dong Z. microRNAs in kidneys: bio- genesis, regulation, and pathophysiological roles. Am J Physiol Renal Physio 2011; 300:F602-10.
  • 4Van Rooij E. The art of microRNA research. CircRes 2011; 108:219-34.
  • 5Lima RT, Busacca S, Almeida GM, et al. microRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 2011; 47:163-74.
  • 6Davis-Dusenbery BN, Hata A. microRNA in Cancer: the involvement of aberrant microRNA biogenesis regula- tory Dathwavs. Genes Cancer 2010: 1:1100-14.
  • 7Farazi TA, Spitzer JI, Morozov P, Tuschi T. miRNAs in human cancer. J Patho12011; 223:102-15.
  • 8Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79:351-79.
  • 9Lin SL, Chang DC, Ying SY, Leu D, Wu DT. micro- RNA miR-302 inhibits the tumorigenecity of humanpluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res 2010; 70:9473-82.
  • 10Pickering MT, Stadler BM, Kowalik TF. miR-17 and miR-20a temper an E2Fl-induced G1 checkpoint to regulate cell cycle progression. Oncogene 2009; 28:140-5.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部